<乌鸦传媒>Death During Sex: Not Just an Old Man Thing But sudden cardiac death remains rare even for sexually active people with heart conditions Jan 12, 2022
<乌鸦传媒>Sapien 3 With Pre-Stent Gets FDA Go-Ahead for Pulmonary Valve Fix Valve system could substantially expand proportion of patients who can skip another surgery Dec 20, 2021
<乌鸦传媒>ECG Monitoring for Post-TAVR Delayed Conduction Disturbances Put to the Test How long should monitoring last, and in whom? Dec 20, 2021
<乌鸦传媒>AHA Abstract Under Fire; Cardiology Bullies; An Acupuncture Needle Where?! Recent developments of interest in cardiovascular medicine Dec 07, 2021
<乌鸦传媒>The Right Ventricle Still Matters in LVAD Patients Right heart failure signaled trouble ahead in the Intermacs registry Nov 29, 2021
<乌鸦传媒>Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozin EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says Nov 16, 2021
<乌鸦传媒>Peak VO2 Improved After Beta-Blocker Withdrawal in Some HFpEF Patients Beta-blockers may not benefit HFpEF patients with chronotropic incompetence Nov 15, 2021
<乌鸦传媒>Stem Cells Don't Prevent Acute Heart Failure Events DREAM-HF trial does hold some positive signals, though Nov 15, 2021
<乌鸦传媒>Tricuspid Repair Boosts Mitral Valve Surgery Outcomes Randomized trial supports combined surgery for moderate regurgitation Nov 13, 2021
<乌鸦传媒>Delaying Surgery Hurts Patients With Silent Aortic Stenosis Early aortic valve replacement wins in AVATAR trial Nov 13, 2021
<乌鸦传媒>Antibiotics Slow Down Latent Rheumatic Heart Disease in Kids GOAL trial supports screening Nov 13, 2021
<乌鸦传媒>Pulmonary Pressure Monitoring Helps HFpEF Too GUIDE-HF substudy supports similar benefits across the ejection fraction spectrum Nov 07, 2021
<乌鸦传媒>More Good News for Empagliflozin in Patients With Heart Failure Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial Nov 06, 2021
<乌鸦传媒>Longstanding Vascular Closure Technique Triumphs Over Collagen Plug Manta versus ProGlide after transfemoral TAVR in CHOICE-CLOSURE Nov 06, 2021
<乌鸦传媒>TAVR Operators Divided on Need for Bicuspid RCT Odds of a study coming to fruition are low Nov 05, 2021
<乌鸦传媒>Too Many TAVR Centers Are Clustered Around Well-to-Do Communities More centers not the answer to geographic, socioeconomic disparities in access? Oct 22, 2021
<乌鸦传媒>Study: Kids Exposed to Harmful Plastics During Heart Surgery Are tubing and blood bags sources of trouble? Oct 09, 2021
<乌鸦传媒>Post-TAVR Pacemakers Not All Doom and Gloom A bit of reassurance from Swedish cohort study Oct 04, 2021
<乌鸦传媒>Post-Vax Myocarditis Fairly Benign Even in a Diverse Population Experience of California health system suggests cases do not disproportionately affect minorities Oct 04, 2021
<乌鸦传媒>FDA Probes LAAO; Dairy Fat's Heart Benefit; Repatha OK'd for Pediatric HeFH Recent developments of interest in cardiovascular medicine Sep 28, 2021
<乌鸦传媒>Low Risk and Bicuspid Anatomy: A Passable Combination for TAVR Thus Far Clinical outcomes not worse compared with tricuspid TAVR Sep 21, 2021
<乌鸦传媒>With HVAD Out, Innovation Key to Mechanical Circulatory Support A debate on where LVAD innovation stands Sep 14, 2021
<乌鸦传媒>Transplant Docs Are Sticking With Invasive Biopsies After Heart Transplants Agreement that non-invasive alternatives to EMB are not ready for routine rejection surveillance Sep 13, 2021
<乌鸦传媒>SGLT2 Inhibitor Eases Symptoms for HFpEF Patients Trial suggests hard outcomes not the only ones helped by this class of medication Sep 13, 2021
<乌鸦传媒>Second-Gen Drug for HCM Emerges, Nipping at Mavacamten's Heels Novel cardiac myosin inhibitor is headed for a phase III trial Sep 12, 2021
<乌鸦传媒>Heart Failure's 'Golden Moment' Not Translating into Better Health Problems of implementation and health equity persist Sep 12, 2021
<乌鸦传媒>Feared ARNI Effect on Cognition Hasn't Come to Fruition Neurocognitive protection by sacubitril/valsartan suggested instead by observational study Sep 12, 2021
<乌鸦传媒>Some Reassurance on Cognition in People With Older LVADs Will newer devices look even better for neurological outcomes? Sep 08, 2021
<乌鸦传媒>Good Results When Giving Flu Shots to MI Survivors Still in the Hospital Vaccination prior to discharge linked to heart benefit Aug 30, 2021
<乌鸦传媒>Polypills Ready for Prime Time in Large Swaths of People, Researchers Say Question now is how to implement fixed-dose combo therapy in clinical practice Aug 29, 2021
<乌鸦传媒>His Bundle Pacing Stars in European Guidelines Revised edition could signal coming U.S. recommendations too Aug 29, 2021
<乌鸦传媒>Ablation, CRT Boost Survival in Permanent Afib With Narrow QRS APAF-CRT trial reinforces the case for expanded CRT indication Aug 28, 2021
<乌鸦传媒>Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S. There is a different approach to deciding the suitability of TAVR, however Aug 28, 2021
<乌鸦传媒>A Familiar Drug Can Keep Early-Stage HCM at Bay Treatment with valsartan most beneficial when started early? Aug 27, 2021
<乌鸦传媒>Empagliflozin Improves Outcomes in HFpEF Patients "A major win" for heart failure with preserved ejection fraction, says editorialist Aug 27, 2021
<乌鸦传媒>New Heart Failure Guidelines Released, but Are They Already Out of Date? Results of EMPEROR-Preserved contradict guidance Aug 27, 2021
<乌鸦传媒>Milder Heart Failure Might Benefit From Implantable Monitors Randomized trial signals benefit, albeit hampered by the pandemic Aug 27, 2021
<乌鸦传媒>Deadly Arrhythmias Less of a Risk for HF Patients on Dapagliflozin DAPA-HF analysis further explores mechanism of SGLT2 inhibitor's heart benefits Aug 27, 2021
<乌鸦传媒>Heart Failure Again Takes Center Stage at ESC EMPEROR-Preserved, new guidelines, and more to come Aug 26, 2021
<乌鸦传媒>Sorensen's PFO Closure Saga; Long QT and Pregnancy Loss; Another LAA Occluder OK'd Recent developments of interest in cardiovascular medicine Aug 17, 2021
